On 12 Nov 2026 Agilent Technologies closed at $173.01, +28.1% this year; market cap $48.96bn, P/E 34.0.
Health Care · Life Sciences Tools & Services · NYSE · United States
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
| Market cap | $48.96bn |
| P/E (trailing) | 34.0 |
| EPS (TTM) | $5.09 |
| Beta | 1.24 |
| Dividend | $1.02 |
| Dividend yield | 0.59% |
| Ex-dividend date | 6 Oct 2026 |
| Latest report | 26 Aug 2026 |
| Next earnings | 23 Nov 2026 |
| YTD | +28.1% |
| 1Y | +15.0% |
| 3Y | +18.1% |
| 5Y | +2.2% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $6.95bn | $1.30bn | $1.15bn |
| 2024 | $6.51bn | $1.29bn | $1.37bn |
| 2023 | $6.83bn | $1.24bn | $1.47bn |
| 2022 | $6.85bn | $1.25bn | $1.02bn |
| 2021 | $6.32bn | $1.21bn | $1.30bn |
We publish no single base value for Agilent Technologies. Our valuation methods put it between $86.02 and $129.27 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.